Blood fibrinogen level as a biomarker of adverse outcomes in patients with coronary artery disease: A systematic review and meta-analysis

BACKGROUND: The association between elevated fibrinogen level and adverse outcomes in patients with coronary artery disease (CAD) remains conflicting. This systematic review and meta-analysis aims to evaluate the association between fibrinogen level and adverse outcomes in CAD patients. METHODS: Rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Zhanqian, Zhao, Guowei, Liu, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387956/
https://www.ncbi.nlm.nih.gov/pubmed/35984145
http://dx.doi.org/10.1097/MD.0000000000030117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387956/
https://www.ncbi.nlm.nih.gov/pubmed/35984145
http://dx.doi.org/10.1097/MD.0000000000030117

Ejemplares similares